Pete grew up in rural upstate NY (not Westchester) with five brothers in an existence that eerily resembled 80s/90s small-town sports movies (we had our own emergency room nurse for 20 years).
As Chief Corporate Development Officer, Pete Rahmer leads business development, corporate strategy, investor relations and external communications. Prior to Relay Therapeutics, Pete was the founder and managing partner of Endurance Advisors, a biotech-focused investor relations and capital markets advisory firm. Prior to Endurance, he was a managing director at the Trout Group and headed the firm’s West Coast practice. Earlier in his career, Pete was part of Thomson Financial’s Biotechnology Capital Markets Intelligence team.
Over the past 17 years, Pete has advised more than 50 companies in capital raising, strategy and investor relations, helping clients raise over $3 billion through capital market offerings over his tenure.
Pete holds a B.A. in economics from St. Lawrence University and an MBA from the Rochester Institute of Technology.